Hjem › Brystkreft › California › Fullerton
Kliniske studier for Brystkreft i Fullerton, CA
9 studier for Brystkreft søker deltakere på steder i og rundt Fullerton (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RekruttererFase 3
- Providence Medical Foundation, Fullerton
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
RekruttererFase 3
- Providence Medical Foundation-Oncology ( Site 0020), Fullerton
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RekruttererFase 3
- Providence Medical Foundation ( Site 0080), Fullerton
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
RekruttererFase 1/2
- Providence Medical Foundation, Fullerton
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RekruttererFase 3
- Providence St. Jude Medical Center - Virginia K. Crosson Cancer Center, Fullerton
E-Mindfulness Approaches for Living After Breast Cancer
RekruttererFase 3
- UCI Health - Yorba Linda, Yorba Linda · 7 mi unna
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
RekruttererFase 3
- Providence Medical Foundation, Fullerton
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Rekrutterer
- St Jude Heritage Medical Group, Fullerton
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
RekruttererFase 2
- St. Joseph Heritage Healthcare, Fullerton
Brystkreft-studier i andre byer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i Fullerton
- Ikke-småcellet lungekreft13 studier
- Eggstokkreft6 studier
- Lupus5 studier
- Kreft (alle typer)5 studier
- Lungekreft4 studier
- Pankreaskreft4 studier
- Mavekreft3 studier
- Spiserørkreft3 studier
- Melanom3 studier
- Plateepitelcancer i hode og hals3 studier
- Schizofreni3 studier
- Kolorektal kreft3 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.